Brown TJ, Yablonovitch A, Till JE, Yen J, et al. The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib. Clin Cancer Res 2023;29:5207-5216.
PMID: 37486343